TYPE 2 DIABETES AND CARDIOVASCULAR COMPLICATIONS: IS IT POSSIBLE TO IMPROVE PROGNOSIS BY GLUCOSE LOWERING THERAPY?

Regardless the fact that type 2 diabetes (DM2) is related to higher risk of cardiovascular diseases (CVD) development and complications, incl. heart failure (HF), usage of the most of glucose lowering drugs (GLD) does not only improve life prognosis, but might increase the risk of HF. Inhibitors of...

Full description

Saved in:
Bibliographic Details
Main Authors: Zh. D. Kobalava, G. К. Kiyakbaev
Format: Artigo
Language:Russo
Published: «FIRMA «SILICEA» LLC 2018-09-01
Series:Российский кардиологический журнал
Subjects:
diabetes type 2
cardiovascular complications
heart failure
glucose lowering therapy
sglt2 inhibitor (gliflozin)
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2918
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items